Search Results

Search

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Off

Ethics Talk: Immunity Status, Social Privilege, and the Novel Coronavirus

Submitted by gale.saulsberr… on

In this video and audio edition of Ethics Talk, journal editor in chief, Audiey Kao, MD, PhD, talks with Kathryn Olivarius, PhD, about how yellow fever epidemics during the antebellum South provide a historical lens to examine power asymmetries and health inequities in the COVID-19 era.

Click here to read the transcript.

Kathryn Olivarius, PhD is an assistant professor of history at Stanford University.

Video

 

Infectious Disease Internal Medicine Patient Care Professionalism

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image videocast3-2005 Issue Sharing Health Decisions CME Off

Ethics Talk: Antiracism, Health Equity, and a Post-COVID Future

Submitted by gale.saulsberr… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Ibram Kendi about the impact of racist policies on historically discriminated-against groups and what it means to be an antiracist.

Click here to read the transcript.

Ibram Kendi, PhD is the founding director of the Antiracist Research and Policy Center and a professor of history and international relations at American University.

Video

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Professionalism Patient Care Header Image videocast1-2006 Issue Portraiture in Health Care CME Off
Case and Commentary
Oct 2019

How Should We Determine the Value of CAR T-Cell Therapy?

Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi: 10.1001/amajethics.2019.844.
Viewpoint
Jun 2008

Medical Care for the Elderly: Should Limits Be Set? Commentary 1

Daniel Callahan, PhD
Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?
Virtual Mentor. 2008;10(6):404-407. doi: 10.1001/virtualmentor.2008.10.6.oped1-0806.